Role of Innate Immune Cells in Psoriasis

Sato, Yukiharu; Ogawa, Emiko; Okuyama, Ryuhei

doi:10.3390/ijms21186604

Cited by 56 publications

(51 citation statements)

References 112 publications

(185 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The cytokines and chemokines from macrophages in turn rescue neutrophils and cause epidermal proliferation were blocked by DMD treatment. (58). Macrophages express low levels of IL-17A (16).…”

Section: Discussionmentioning

confidence: 99%

2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation

et al. 2021

View full text Add to dashboard Cite

Antrodia cinnamomea exhibits anti-inflammatory, antioxidant, and immunomodulatory activities. We aimed to explore the antipsoriatic potential of 2,4-dimethoxy-6-methylbenzene-1,3-diol (DMD) derived from A. cinnamomea. The macrophages activated by imiquimod (IMQ) were used as the cell model for examining the anti-inflammatory effect of DMD in vitro. A significantly high inhibition of IL-23 and IL-6 by DMD was observed in THP-1 macrophages and bone marrow-derived mouse macrophages. The conditioned medium of DMD-treated macrophages could reduce neutrophil migration and keratinocyte overproliferation. DMD could downregulate cytokine/chemokine by suppressing the phosphorylation of mitogen-activated protein kinases (MAPKs) and NF-κB. We also observed inhibition of GDAP1L1/Drp1 translocation from the cytoplasm to mitochondria by DMD intervention. Thus, mitochondrial fission could be a novel target for treating psoriatic inflammation. A psoriasiform mouse model treated by IMQ showed reduced scaling, erythema, and skin thickening after topical application of DMD. Compared to the IMQ stimulation only, the active compound decreased epidermal thickness by about 2-fold. DMD diminished the number of infiltrating macrophages and neutrophils and their related cytokine/chemokine production in the lesional skin. Immunostaining of the IMQ-treated skin demonstrated the inhibition of GDAP1LI and phosphorylated Drp1 by DMD. The present study provides insight regarding the potential use of DMD as an effective treatment modality for psoriatic inflammation.

show abstract

Section: Discussionmentioning

confidence: 99%

2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Gamma delta (γδ) T lymphocytes have a γδ T-cell receptor and share the properties of adaptive and innate immunity [ 63 ]. Two γδ T-cells’ subpopulations, dermal γδ T lymphocytes and circulating Vγ9Vδ2 lymphocytes, have been found in psoriasis [ 64 ].…”

Section: Immunopathogenesis Of Psoriasismentioning

confidence: 99%

Current Concepts of Psoriasis Immunopathogenesis

Vičić

Kaštelan

Brajac

et al. 2021

IJMS

View full text Add to dashboard Cite

Psoriasis is a recurrent, chronic, immune-mediated, systemic inflammatory disease of the skin, joints, and other organic systems. After atopic dermatitis, chronic stationary psoriasis is the most common inflammatory skin disease, affecting an average of 2–4% of the world’s population. The disease carries a significant burden due to its numerous comorbidities and the major impact on patients’ social and emotional aspects of life. According to current knowledge, psoriasis is a multifactorial disease that occurs in genetically predisposed individuals under various environmental factors, which trigger an immune response disorder with a series of complex inflammatory cascades. The disease is initiated and maintained by mutual interaction of the innate and adaptive immune cells, primarily dendritic cells, T lymphocytes, and keratinocytes, whose leading role alternates at different stages of the disease, consisting mainly in the IL-23/Th17 pathway. Inflammatory events result in consequent epidermal and dermal changes and evolution of the characteristic psoriatic phenotype, respectively. This paper aims to present a comprehensive overview of current knowledge on psoriasis genetic and environmental etiological factors, immunopathogenesis, and the leading cellular and cytokine participants in the inflammatory pathways of this disease.

show abstract

“…ILCs may be more important in IL-17 production than T cells because deleting T cells from two mouse models of psoriasis does not abolish skin hyperplasia, but deleting ILCs does [ 113 ]. The ILC3 subclass are disproportionately abundant in the blood and skin lesions of psoriasis patients and are classified by their production of IL-17 and IL-22, both cytokines that are key in the induction of keratinocyte proliferation [ 114 , 115 ]. Further investigation into means of targeting ILC3s may lead to novel psoriatic therapeutics.…”

Section: Barrier Aberration In Psoriasismentioning

confidence: 99%

Skin Barrier Dysregulation in Psoriasis

Andreas

Bereza-Malcolm

Lynch

et al. 2021

IJMS

View full text Add to dashboard Cite

The skin barrier is broadly composed of two elements—a physical barrier mostly localised in the epidermis, and an immune barrier localised in both the dermis and epidermis. These two systems interact cooperatively to maintain skin homeostasis and overall human health. However, if dysregulated, several skin diseases may arise. Psoriasis is one of the most prevalent skin diseases associated with disrupted barrier function. It is characterised by the formation of psoriatic lesions, the aberrant differentiation and proliferation of keratinocytes, and excessive inflammation. In this review, we summarize recent discoveries in disease pathogenesis, including the contribution of keratinocytes, immune cells, genetic and environmental factors, and how they advance current and future treatments.

show abstract

Role of Innate Immune Cells in Psoriasis

Cited by 56 publications

References 112 publications

2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation

2,4-Dimethoxy-6-Methylbenzene-1,3-diol, a Benzenoid From Antrodia cinnamomea, Mitigates Psoriasiform Inflammation by Suppressing MAPK/NF-κB Phosphorylation and GDAP1L1/Drp1 Translocation

Current Concepts of Psoriasis Immunopathogenesis

Skin Barrier Dysregulation in Psoriasis

Contact Info

Product

Resources

About